You are here


Genome Canada was established in February 2000 under the Canada Corporations Act and, in 2012, was issued new Articles of Continuance under the Canada Not-for-Profit Corporations Act.

Genome Canada is governed by a board of directors comprising individuals drawn from the academic, private and public sectors. These individuals bring unique skills and experiences as well as strong interests and insights to successfully fulfil Genome Canada’s strategic plan. Furthermore, the presidents of five federal research funding agencies are nonvoting, ex officio advisors to the board of directors. The science and industry advisory committee is a permanent committee of Genome Canada’s board of directors.